Regeneron Pharmaceuticals Inc. - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

RD Technologies expands Ghana-Asia payment push with RDUSD as it shifts towards stablecoin settlement

Florida jet crash kills nine as Learjet 60 plunges near homes in Palm Beach County

Westpac reports A$6.8bn profit as bad debt charges double and lending margins tighten

McCain Foods expands India manufacturing footprint with Falcon Agrifriz acquisition as frozen potato demand grows

Representative image: AbbVie’s reported $10.9 billion Apogee Therapeutics acquisition talks highlight investor focus on zumilokibart, immunology pipeline expansion and the high-risk race to build growth beyond Humira.

Read More

Pharma Industry News

AbbVie weighs $10.9bn Apogee deal to strengthen its next immunology growth cycle

AbbVie may pay $10.9 billion for Apogee Therapeutics before Phase 3. Read what the reported deal could mean for immunology growth and ABBV stock.

June 22, 2026

web analytics